Characterizing Adverse Events Reported Immediately After Osteopathic Manipulative Treatment.
Brian F Degenhardt, Jane C Johnson, William J Brooks...
https://pubmed.ncbi.nlm.nih.gov/29480914/Actively Recruiting
Led by Burrell College of Osteopathic Medicine · Updated on 2025-01-09
32
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate whether osteopathic manipulative treatment OMT can help adults who lost their sense of smell due to COVID-19 recover their olfactory perception. Loss of smell is a common symptom of COVID-19 that can lower quality of life and pose safety risks. The study also seeks to understand how long any improvement in smell lasts after treatment. Participants will be randomly assigned to receive either OMT or a sham treatment. OMT involves two specific procedures occipitoatlantal decompression using 12N of pressure for 2 minutes, and treatment of the nasal Chapman points while lying down. The sham treatment involves the investigator resting their hands gently on the sides of the participants neck for 5 minutes. The study includes initial smell testing before and after treatment, as well as follow-up tests the next day and within 1 to 2 weeks. During the study, participants will undergo smell tests using the validated Sniffin Sticks protocol in a well-ventilated area. Testing occurs before treatment, immediately after, daily for up to 10 days, and at follow-up visits. Researchers will monitor changes in smell ability and assess the duration of any improvements. Safety and adherence are observed throughout, with participants wearing masks during evaluations. The total participation spans from enrollment until two weeks post-treatment to measure recovery of smell.
CONDITIONS
Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19
T
Thomas P Eiting, Ph.D
A
Adrienne Kania, D.O.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Burrell College of Osteopathic Medicine
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | OMT (Investigational Treatment) | Sham Treatment (Control) |
|---|---|---|
| What is it? | A hands-on treatment protocol using occipitoatlantal decompression and Chapman point techniques performed by a trained osteopathic physician with the intention of improving anosmia after COVID-19. | A control procedure where gentle hand contact is maintained on the neck for 5 minutes, without performing therapeutic manipulations. |
| Role in the trial | Assessed as the experimental intervention tested for its ability to restore olfactory function in those experiencing anosmia after COVID-19. | Serves as the trial's control, used to assess whether any observed improvement is attributable to OMT rather than investigator contact or participant expectation. |
| Primary use | Intended to promote recovery of smell in adults who lost olfactory function following COVID-19 infection. | Acts as an inactive control, designed to resemble the clinical process of OMT without providing its active therapies. |
| How is it given or performed? | The patient lies on their back while a physician applies occipitoatlantal decompression and stimulates nasal Chapman points using specific hands-on techniques, lasting several minutes total per session. | The participant lies supine while the practitioner's hands rest gently on the sides of the neck for 5 minutes, with no manipulative actions performed. |
| Evidence status | The effectiveness of OMT to restore sense of smell post-COVID-19 remains under clinical investigation, with promising results in general for OMT's supportive role in other COVID-19 settings but no published efficacy specifically for anosmia after COVID-19 to date. | As an inactive comparator, the sham treatment is not expected to provide direct benefit for smell recovery, but serves to control for patient expectation in the trial. |
| Important risks | OMT is generally considered safe when performed by trained practitioners, with only mild and short-lived adverse events (e.g., temporary soreness) observed in large studies of osteopathic manipulative procedures. | No meaningful intervention or manipulation is performed; no clinically significant risk is expected with gentle hand placement. |
| Important limitations | There is a lack of published high-quality studies specifically evaluating OMT for post-COVID-19-related anosmia, and findings cannot be generalized to all individuals with olfactory loss or other causes of anosmia. | As a non-therapeutic comparator, the sham procedure does not represent an established therapy or usual care outside the research setting. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Single day
Participants receive either osteopathic manipulative treatment (OMT) or a sham intervention. The OMT includes occipitoatlantal decompression and treatment of the nasal Chapman point. The sham treatment involves a gentle resting of the investigator's hands on the subject's neck. Olfactory testing is done before and after the intervention to assess sense of smell.
1 treatment visit with pre- and post-intervention olfactory testing (in-person)
Duration - Up to 2 weeks
Participants return for daily olfactory testing for up to 10 days to monitor the effect of the treatment or spontaneous recovery. Additional follow-up visits occur within 1 to 2 weeks after treatment to assess ongoing olfactory recovery.
Daily visits for up to 10 days and 1 final visit within 1 to 2 weeks post treatment (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Brian F Degenhardt, Jane C Johnson, William J Brooks...
https://pubmed.ncbi.nlm.nih.gov/29480914/Benna Jacob, Mehak Sawhney, Aarthi Sridhar...
https://pubmed.ncbi.nlm.nih.gov/37079451/Adrienne M Kania, Kailee N Weiler, Angeline P Kurian...
https://pubmed.ncbi.nlm.nih.gov/33694358/Teresa P Nguyen, Zara M Patel
https://pubmed.ncbi.nlm.nih.gov/29901865/Magdalena Eriksson Domellöf, Karl-Fredrik Lundin, Mona Edström...
https://pubmed.ncbi.nlm.nih.gov/28242255/Gordon H Sun, Cyrus A Raji, Mark P Maceachern...
https://pubmed.ncbi.nlm.nih.gov/22552846/Keiland W Cooper, David H Brann, Michael C Farruggia...
https://pubmed.ncbi.nlm.nih.gov/32640192/T Hummel, B Sekinger, S R Wolf...
https://pubmed.ncbi.nlm.nih.gov/9056084/Katherine Lisa Whitcroft, Thomas Hummel
https://pubmed.ncbi.nlm.nih.gov/32432682/Ho Sik Moon, Jin Young Chon, Sang Hoon Lee...
https://pubmed.ncbi.nlm.nih.gov/23342209/Burrell College of Osteopathic Medicine
Lead Sponsor